The Effect of SARS-CoV-2 Spike Protein RBD-Epitope on Immunometabolic State and Functional Performance of Cultured Primary Cardiomyocytes Subjected to Hypoxia and Reoxygenation
Authors:
- Vytenis KeturakisVKVytenis Keturakis
- Deimantė NarauskaitėDNDeimantė Narauskaitė
- Zbigniev BalionZBZbigniev Balion
- Dovydas GečysDGDovydas Gečys
- Gabrielė KulkovienėGKGabrielė Kulkovienė
- Milda KairytėMKMilda Kairytė
- Ineta ŽukauskaitėIŽIneta Žukauskaitė
- Rimantas BenetisRBRimantas Benetis
- Edgaras StankevičiusEdgaras Stankevičius
- Aistė JekabsoneAistė Jekabsone
Open Access
- 21 November 2023
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (23) , 16554
Abstract
Cardio complications such as arrhythmias and myocardial damage are common in COVID-19 patients. SARS-CoV-2 interacts with the cardiovascular system primarily via the ACE2 receptor. Cardiomyocyte damage in SARS-CoV-2 infection may stem from inflammation, hypoxia–reoxygenation injury, and direct toxicity; however, the precise mechanisms are unclear. In this study, we simulated hypoxia–reoxygenation conditions commonly seen in SARS-CoV-2-infected patients and studied the impact of the SARS-CoV-2 spike protein RBD-epitope on primary rat cardiomyocytes to gain insight into the potential mechanisms underlying COVID-19-related cardiac complications. Cell metabolic activity was evaluated with PrestoBlueTM. Gene expression of proinflammatory markers was measured by qRT-PCR and their secretion was quantified by Luminex assay. Cardiomyocyte contractility was analysed using the Myocyter plugin of ImageJ. Mitochondrial respiration was determined through Seahorse Mito Stress Test. In hypoxia–reoxygenation conditions, treatment of the SARS-CoV-2 spike RBD-epitope reduced the metabolic activity of primary cardiomyocytes, upregulated Il1β and Cxcl1 expression, and elevated GM-CSF and CCL2 cytokines secretion. Contraction time increased, while amplitude and beating frequency decreased. Acute treatment with a virus RBD-epitope inhibited mitochondrial respiration and lowered ATP production. Under ischaemia-reperfusion, the SARS-CoV-2 RBD-epitope induces cardiomyocyte injury linked to impaired mitochondrial activity.Keywords
Funding Information
- Lietuvos Mokslo Taryba (01.2.2-LMT-K-718-05-0052)
This publication has 50 references indexed in Scilit:
- The physiological role of cardiac cytoskeleton and its alterations in heart failureBiochimica et Biophysica Acta (BBA) - Biomembranes, 2014
- The Na+/Ca2+ exchanger in cardiac ischemia/reperfusion injuryMedical Science Monitor, 2012
- Virus Entry by EndocytosisAnnual Review of Biochemistry, 2010
- SARS‐coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARSEuropean Journal of Clinical Investigation, 2009
- Regulation of ACE2 in cardiac myocytes and fibroblastsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't knowCell Research, 2006
- The SARS epidemic in Hong Kong: what lessons have we learned?Journal of the Royal Society of Medicine, 2003
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000
- Mechanisms of Cardiomyocyte Dysfunction in Heart Failure Following Myocardial Infarction in RatsJournal of Molecular and Cellular Cardiology, 1998
- Mitochondrial respiration following acute hypoxia in the perfused rat heartJournal of Molecular and Cellular Cardiology, 1985